EICHORCondition: Acne · Acne Vulgaris · Skin Health · Sponsor: Parea INC dba Cool as a Cucumber
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This single-group, open-label clinical trial examines the efficacy of Cool as a Cucumber's Acne Treatment Serum in adults with acne-prone skin. The study will enroll 25 male and female participants between the ages of 24 and 47 who will use the serum for eight weeks, with assessments conducted virtually at Baseline, Week 4, and Week 8. The primary objective is to evaluate the effects of the Acne Treatment Serum on facial acne using the Validated Acne Quality-of-Life Scale (Acne QoL) and expert-graded before-and-after photographs. Secondary objectives include evaluating changes in skin texture, uneven skin tone, hyperpigmentation, redness, sebum production, and fine lines and wrinkles via self-reported questionnaires.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Male or female between the ages of 24-47 (between 2-4 males, the remainder females) * Actively has acne (non-inflamed and/or inflamed acne) * Has previously used or is currently using exfoliating acids (AHAs / BHA) and is willing to stop this for the duration of the study * Has not experienced sunburn on the face in the last month * No open wounds, sores, or non-acne related lesions on the face * Generally healthy - don't live with any uncontrolled chronic disease * Willing to apply SPF on a daily basis during the study and to use other sun protection on the face (i.e. a hat) * Must be willing to avoid products with coconut oil and shea butter, and Ethylhexyl Palmitate for the duration of the study * Must be willing to cut out whey protein and cow's milk from their diet for the duration of the study * Must be willing to avoid biotin products or supplements for the duration of the study * Must agree to avoid sun tanning, tanning beds, and self-tanning products for the duration of the study Exclusion Criteria: * Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone with known severe allergic reactions * Women who are pregnant, breastfeeding or attempting to become pregnant * Unwilling to follow the study protocol * Smoker * Anyone consuming products containing Tetrahydrocannabinol (THC) * Identifies as a person with sensitive skin * Anyone currently on steroids or undergoing hormone replacement therapy * Anyone using prescription medication relevant to the skin * Undergoing any cosmetic procedures during the study including facials, Botox, dermal filler, laser, or chemical peel treatments * Use of prescription drug (topical or oral) that is targeted at any sort of skin condition (e.g., retinoids, accutane) * Anyone allergic to niacinamide or salicylic acid * Anyone who regularly consumes biotin supplements and is unwilling to stop for the duration of the study * Participants who stopped using birth control within the past 3 months * Participants currently have a Copper IUD or are using one of the following birth control high in androgen and low in estrogen activity: Amethyst, Jolessa, Lessina, Levonest/Levora, Lutera, Nordette, Portia, Seasonale/Seasonique, Sronyx, Mirena IUD, Triphasil/Trivora, Cryselle, Lo-Ovral/Ovral, Low-Ogestrel/Ogestrel, Lo-Feminol, Ortho tricyclen Lo, Estrostep Fe, Loestrin, Microgestin, Apri, Mircette, Azurette, Caziant, Cyclessa, Desogen, Emoquette, Kariva, Linessa, Marvelon, NuvaRing, Depo-Provera, Reclipsen
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Citruslabs | Las Vegas, Nevada, United States | — |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07752368